7726.TWO Carilex Medical, Inc.
- Market cap
- TWD 653M
- P/E
- -
- P/B
- 2.20x
- ROE
- -10.0%
- Dividend yield
- 1.77%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 7726.TWO undervalued?
Graham numberThe Graham number of Carilex Medical, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Carilex Medical, Inc. fundamental analysis
No fundamental analysis for Carilex Medical, Inc. yet.
Carilex Medical, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Carilex Medical, Inc.
Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide. It offers support surfaces, chair cushions, and negative pressure wound therapy products to prevent and manage pressure sores and wounds. The company was founded in 1985 and is headquartered in Taoyuan City, Taiwan.
Full company profileCarilex Medical, Inc. financial statements
Carilex Medical, Inc. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 347M | 388M | 335M | 466M | 352M | 339M |
| Gross Profit | 154M | 169M | 143M | 197M | 150M | 99.1M |
| Operating Income | 73.0M | 52.2M | 17.6M | 55.4M | 3.03M | -42.8M |
| EBITDA | 85.2M | 59.6M | 56.2M | 78.8M | 42.7M | -5.43M |
| Net Income | 53.1M | 32.3M | 28.9M | 44.4M | 13.5M | -29.0M |
| EPS | 3.84 | 2.29 | 1.69 | 2.44 | 0.74 | -1.43 |
| Balance Sheet | ||||||
| Total Assets | 354M | 417M | 415M | 543M | 460M | 534M |
| Total Liabilities | 139M | 213M | 178M | 192M | 130M | 243M |
| Shareholders' Equity | 216M | 204M | 237M | 351M | 330M | 291M |
| Cash & Short-term Investments | 105M | 139M | 129M | 173M | 137M | 224M |
| Total Debt | 85.9M | 98.9M | 102M | 72.4M | 71.9M | - |
| Cash Flow | ||||||
| Operating Cash Flow | 45.8M | 78.8M | 33.2M | 1.96M | 25.0M | 46.6M |
| Capital Expenditure | 1.53M | 1.56M | 28.2M | 6.67M | 2.93M | 10.5M |
| Free Cash Flow | 44.3M | 77.2M | 4.86M | -4.70M | 22.0M | 36.0M |
| Ratios | ||||||
| ROE | 24.6% | 15.9% | 12.2% | 12.6% | 4.1% | -10.0% |
| ROA | 15.0% | 7.8% | 7.0% | 8.2% | 2.9% | -5.4% |
| Net Profit Margin | 15.3% | 8.3% | 8.6% | 9.5% | 3.8% | -8.6% |
| Debt to Equity | 0.40x | 0.49x | 0.43x | 0.21x | 0.22x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Carilex Medical, Inc. dividends
- Dividend yield
- 1.77%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 1, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 11.6M | 0.57 | - |
| 2024 | TWD 35.9M | 1.97 | 266.7% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | TWD 48.4M | 3.43 | 149.7% |
| 2020 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Carilex Medical, Inc.
Ownership data of Carilex Medical, Inc. is not available yet.
Carilex Medical, Inc. company profile
- Company name
- Carilex Medical, Inc.
- Ticker
- 7726.TWO
- ISIN
- TW0007726002
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- December
- Address
- No.77, Keji 1st Road, Taoyuan City, Taiwan, 33383
- Phone
- 886 3 328 7882
- Website
- carilexmedical.com
About Carilex Medical, Inc.
Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide. It offers support surfaces, chair cushions, and negative pressure wound therapy products to prevent and manage pressure sores and wounds. The company was founded in 1985 and is headquartered in Taoyuan City, Taiwan.
Carilex Medical, Inc. management
2- Mr. Zhiwei WangGeneral Manager
- Ms. Soumi PanAccounting Manager